Sang-Mi Jin

Title: Sang-Mi Jin: Innovator in Pharmaceutical Chemistry

Introduction

Sang-Mi Jin is a notable inventor based in Yongin, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on benzoisoxazole derivatives. His research focuses on improving the bioavailability of these compounds, which have important therapeutic applications.

Latest Patents

Sang-Mi Jin holds a patent for "3-amido-1,2-benzoisoxazole derivatives, process for preparation, and use thereof." This invention relates to 3-amido-1,2-benzoisoxazole derivatives and their salts, which are represented by a specific formula. The patent outlines a method for enhancing bioavailability by introducing an amino acid residue to the amine group of the compound. These derivatives serve as antagonists against the Leukotriene-B-4 receptor and are potential therapeutics for osteoporosis, inhibiting osteolysis and stimulating osteogenesis. He has 1 patent to his name.

Career Highlights

Throughout his career, Sang-Mi Jin has worked with prominent companies in the pharmaceutical industry, including Dongwha Pharm. Ind. Co., Ltd. and Dong Wha Pharm. Co., Ltd. His work has been instrumental in advancing the development of new therapeutic agents.

Collaborations

Sang-Mi Jin has collaborated with several professionals in his field, including Jin-soo Lee and Eun-Joo Kim. These collaborations have contributed to the success of his research and the development of innovative pharmaceutical solutions.

Conclusion

Sang-Mi Jin is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the treatment of various medical conditions. His innovative approach to developing benzoisoxazole derivatives showcases his commitment to improving healthcare through scientific research.